Christopher Lowe
Board Member
Quince Therapeutics, Inc. (QNCX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-02-02–present
-
Current
-
2022-01-01–2022-06-08
-
Start not stated–2022-06-10
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Quince Therapeutics, Inc. (QNCX) | Former Interim Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer and Treasurer | $225,888 | $3,400,870 |
| 2021 | Quince Therapeutics, Inc. (QNCX) | Former Interim Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer and Treasurer | $445,000 | $2,123,652 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.